Antidote for Valproic Acid Toxicity: a New Indication for Meropenem Antibiotic.
Clinical trial NCT04671589 · UNKNOWN
Trial details
- NCT number
- NCT04671589
- Sponsor
- Mabaret Al-Asafara Hospitals
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-01
- Primary completion
- 2022-06-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.